Artificial intelligence for COVID-19 drug discovery and vaccine development

A Keshavarzi Arshadi, J Webb, M Salem… - Frontiers in Artificial …, 2020 - frontiersin.org
SARS-COV-2 has roused the scientific community with a call to action to combat the growing
pandemic. At the time of this writing, there are as yet no novel antiviral agents or approved …

[HTML][HTML] Artificial intelligence for COVID-19: rapid review

J Chen, KC See - Journal of medical Internet research, 2020 - jmir.org
Background COVID-19 was first discovered in December 2019 and has since evolved into a
pandemic. Objective To address this global health crisis, artificial intelligence (AI) has been …

Machine and deep learning towards COVID-19 diagnosis and treatment: survey, challenges, and future directions

T Alafif, AM Tehame, S Bajaba, A Barnawi… - International journal of …, 2021 - mdpi.com
With many successful stories, machine learning (ML) and deep learning (DL) have been
widely used in our everyday lives in a number of ways. They have also been instrumental in …

Drug repurposing for COVID-19: Approaches, challenges and promising candidates

YL Ng, CK Salim, JJH Chu - Pharmacology & therapeutics, 2021 - Elsevier
Traditional drug development and discovery has not kept pace with threats from emerging
and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV …

A survey on applications of artificial intelligence in fighting against COVID-19

J Chen, K Li, Z Zhang, K Li, PS Yu - ACM Computing Surveys (CSUR), 2021 - dl.acm.org
The COVID-19 pandemic caused by the SARS-CoV-2 virus has spread rapidly worldwide,
leading to a global outbreak. Most governments, enterprises, and scientific research …

Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19

D Barh, S Tiwari, ME Weener, V Azevedo… - Computers in biology …, 2020 - Elsevier
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at
present. Although several FDA-approved drugs are currently under clinical trials for drug …

A systematic review on AI/ML approaches against COVID-19 outbreak

O Dogan, S Tiwari, MA Jabbar, S Guggari - Complex & Intelligent Systems, 2021 - Springer
Abstract A pandemic disease, COVID-19, has caused trouble worldwide by infecting millions
of people. The studies that apply artificial intelligence (AI) and machine learning (ML) …

Rutin: A Potential Antiviral for Repurposing as a SARS-CoV-2 Main Protease (Mpro) Inhibitor

PK Agrawal, C Agrawal… - Natural Product …, 2021 - journals.sagepub.com
Various computational studies, including in silico ones, have identified several existing
compounds that could serve as effective inhibitors of the SARS-CoV-2 main protease …

Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine

Y Lin, Y Zhang, D Wang, B Yang, YQ Shen - Phytomedicine, 2022 - Elsevier
Abstract Background Traditional Chinese medicine (TCM), as a significant part of the global
pharmaceutical science, the abundant molecular compounds it contains is a valuable …

[HTML][HTML] Machine learning research towards combating COVID-19: Virus detection, spread prevention, and medical assistance

O Shahid, M Nasajpour, S Pouriyeh, RM Parizi… - Journal of Biomedical …, 2021 - Elsevier
COVID-19 was first discovered in December 2019 and has continued to rapidly spread
across countries worldwide infecting thousands and millions of people. The virus is deadly …